Following the recent announcement by the National Narcotics Control Office, which designated 16 substances—including difluoroethylmethyl ester—as controlled under the “Catalog of Non-Medical Anesthetic and Psychotropic Substances” effective July 1, China’s fine chemical industry has once again faced a major test in ensuring compliance. In response to this increasingly stringent regulatory environment, Shijiazhuang Pengnuo Technology Co., Ltd. (hereinafter referred to as “Pengnuo Technology”) swiftly took action: not only conducting a comprehensive self-inspection to ensure business compliance but also seizing this opportunity to demonstrate its confidence as a responsible supplier. By focusing on the R&D and production of high-purity, technologically advanced legal pharmaceutical intermediates, Pengnuo Technology is replacing outdated production capacities with “green synthesis” technologies, thereby providing global customers with safe, compliant, and high-quality chemical solutions.
In response to the national call, build a robust “firewall” for compliant operations.
Among the 16 substances newly placed under control this time are various cathinone and phencyclidine derivatives that pose potential abuse risks.
Matters. For fine chemical enterprises, this is not only a legal red line but also a reflection of corporate social responsibility. The management of Pengnuo Technology explicitly stated: “Compliance is the lifeline of our company. We firmly support the decision made by the National Narcotics Control Office and have immediately activated our internal compliance review mechanism.” The company emphasized that Pengnuo Technology’s product portfolio has always been focused on therapeutic drug intermediates and functional material monomers—such as pyrazolone derivatives used in the synthesis of antipyretic and analgesic drugs, and benzenesulfonate salts used in cardiovascular medications. All these products have clear medicinal or industrial applications and are backed by a comprehensive downstream traceability system. The company pledges to never cross the legal red line and will actively cooperate with regulatory authorities, leveraging its expertise in chemical synthesis to help identify and prevent the illegal circulation of related hazardous substances.
Technology for Good: Using “High-Difficulty Synthesis” to Serve Legitimate Medical Needs
While eliminating risky substances, Pengnuo Technology is channeling more R&D resources into the field of pharmaceutical intermediates—areas that genuinely benefit humanity. In response to the stringent global demands on the purity and impurity control of active pharmaceutical ingredients, Pengnuo Technology leverages its accumulated expertise in nitrogen-containing heterocycle construction, fluorination reactions, and chiral synthesis to tackle the “bottleneck” challenges in the lawful synthesis of drugs. For instance, in response to the current popularity of GLP-1 receptor agonists (weight-loss drugs) and targeted anti-cancer therapies, Pengnuo Technology has developed multiple efficient, low-pollution synthetic routes. Take, as an example, the company’s core product—the fluorinated benzaldehyde series: by optimizing the catalytic system, Pengnuo Technology has not only significantly improved yields but also effectively reduced the formation of byproducts, thereby eliminating at the source any possibility of generating structures similar to those of controlled substances. This “technology for good” philosophy enables Pengnuo Technology’s products to enjoy strong competitiveness in the international market—customers are purchasing not just chemicals, but also a guarantee of “safety” and “compliance.”
Reject “wild growth” and build a transparent supply chain.
In today’s complex international trade environment, overseas customers are increasingly stringent in their compliance reviews of Chinese suppliers. Pengnuo Technology deeply understands that only by establishing a transparent supply chain system can we earn lasting trust. To this end, the company has established a rigorous system for customer onboarding and use-purpose review. Before any order is shipped, it must undergo multiple layers of review to ensure that the products are used solely for legitimate scientific research or industrial production. At the same time, Pengnuo Technology actively promotes an EHS (Environment, Health, and Safety) management system, strictly adhering to national standards throughout the production process to ensure that emissions of the three types of waste meet regulatory requirements. This dual commitment to compliance and environmental protection has made Pengnuo Technology the preferred partner for numerous multinational pharmaceutical companies and leading domestic pharmaceutical manufacturers.
Conclusion
At a time when the country is cracking down hard on drug-related crimes and tightening regulations on chemical management, Shijiazhuang Pengnuo Technology Co., Ltd. has demonstrated through its actions that the future of fine chemicals lies not in “being able to do everything,” but in “focusing on specialization, pursuing excellence, and acting with integrity.” Moving forward, Pengnuo Technology will continue to uphold the development philosophy of “compliance, innovation, and sustainability,” accelerating its progress along a lawful path and contributing the “Pengnuo Power” to the high-quality development of China’s pharmaceutical and chemical industry.
www.pengnuochemical.com
Shijiazhuang Pengnuo Technology Co., Ltd.
Post time: Jun-18-2026